AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
2001 JAN 11 - (NewsRx.com) -- BioSphere Medical, Inc., a medical device company pursuing the use of bioengineered microspheres to treat hypervascularized tumors and vascular malformations by occluding their blood supply, announced December 14, 2000, the first patient treatment in the Phase II pivotal trial of the company's leading product, Embosphere[R] Microspheres, to treat uterine fibroids.
The treatment was performed by Robert Worthington-Kirsch, at Roxborough Memorial Hospital in Philadelphia, Pennsylvania. Worthington-Kirsch has performed over 850 uterine artery embolization (UAE) procedures, more than any other physician in the world.
"I am delighted to be a part of this important clinical ...
Source: HighBeam Research, Clinical Trial Investigates Microsphere Treatment.(for uterine...